×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OCS – oculis holding ag (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OCS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/13
07:46 pm
ocs
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares [Yahoo! Finance]
Low
Report
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares [Yahoo! Finance]
2/13
07:39 pm
ocs
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares
Low
Report
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares
2/6
06:32 am
ocs
We're Hopeful That Oculis Holding (NASDAQ:OCS) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That Oculis Holding (NASDAQ:OCS) Will Use Its Cash Wisely [Yahoo! Finance]
1/7
08:20 am
ocs
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
Low
Report
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
1/6
12:46 pm
ocs
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Oculis Holding AG (NASDAQ: OCS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
1/6
03:53 am
ocs
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy
Low
Report
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
2/14
04:29 pm
ocs
Form 6-K Oculis Holding AG For: Feb 14
Neutral
Report
Form 6-K Oculis Holding AG For: Feb 14
2/12
04:30 pm
ocs
Form SCHEDULE 13G/A Oculis Holding AG Filed by: LSP 7 Cooperative UA
Low
Report
Form SCHEDULE 13G/A Oculis Holding AG Filed by: LSP 7 Cooperative UA
1/6
04:05 pm
ocs
Form 6-K Oculis Holding AG For: Jan 06
Medium
Report
Form 6-K Oculis Holding AG For: Jan 06
1/3
04:45 pm
ocs
Form SCHEDULE 13G/A Oculis Holding AG Filed by: Brunnur vaxtarsjodur slhf
Low
Report
Form SCHEDULE 13G/A Oculis Holding AG Filed by: Brunnur vaxtarsjodur slhf
12/9
09:44 pm
ocs
Form SC 13G Oculis Holding AG Filed by: Pivotal bioVenture Partners Fund I, L.P.
Low
Report
Form SC 13G Oculis Holding AG Filed by: Pivotal bioVenture Partners Fund I, L.P.
11/29
01:05 pm
ocs
Form 6-K Oculis Holding AG For: Nov 29
Neutral
Report
Form 6-K Oculis Holding AG For: Nov 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: